Renaissance Technologies - CANCER GENETICS INC ownership

CANCER GENETICS INC's ticker is CGIX and the CUSIP is 13739U203. A total of 11 filers reported holding CANCER GENETICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of CANCER GENETICS INC
ValueSharesWeighting
Q4 2020$673,000
-16.2%
242,801
+25.5%
0.00%0.0%
Q3 2020$803,000
+52.7%
193,401
+11.5%
0.00%
Q2 2020$526,000
+18.7%
173,501
+7.8%
0.00%
Q1 2020$443,000
-55.7%
160,942
-4.2%
0.00%
-100.0%
Q4 2019$1,001,000168,0320.00%
Other shareholders
CANCER GENETICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Mayo Clinic 444$184,0000.25%
Renaissance Technologies 193,401$803,0000.00%
UBS Group AG 558$2,0000.00%
OSAIC HOLDINGS, INC. 433$2,0000.00%
WELLS FARGO & COMPANY/MN 14$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MORGAN STANLEY 37$00.00%
ACADIAN ASSET MANAGEMENT LLC 18,001$75,0000.00%
BlackRock Inc. 36,665$152,0000.00%
CAPTRUST FINANCIAL ADVISORS 50$00.00%
View complete list of CANCER GENETICS INC shareholders